Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27399
Title: Pulmonary embolus in patients with COVID-19: an Australian perspective.
Austin Authors: Robinson, Danielle H ;Wimaleswaran, Hari ;McDonald, Christine F ;Howard, Mark E ;Willcox, Abbey 
Affiliation: Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
Respiratory and Sleep Medicine
Institute for Breathing and Sleep
Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia
Clinical Haematology
Issue Date: Aug-2021
Publication information: Internal Medicine Journal 2021; 51(8): 1324-1327
Abstract: Pulmonary embolus (PE) is a known complication of coronavirus disease 2019 (COVID-19). The diagnosis of PE in our hospitalised patients with COVID-19 correlated with more severe disease and occurred despite the use of routine thromboprophylaxis. Higher D-dimers were seen on admission in patients who developed PE and rose at PE diagnosis, suggesting a role for D-dimer in risk stratification.
URI: https://ahro.austin.org.au/austinjspui/handle/1/27399
DOI: 10.1111/imj.15405
ORCID: 0000-0003-0384-704X
Journal: Internal Medicine Journal
PubMed URL: 34423548
Type: Journal Article
Subjects: COVID-19
D-dimer
pulmonary embolism
thrombosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

42
checked on Jul 15, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.